| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 14 | 40 | -1,66 % | ||
| VESTAS WIND SYSTEMS | 6 | 9 | +1,30 % | ||
| DSV | 6 | 4 | -4,00 % | ||
| CARLSBERG | 4 | 3 | +2,02 % | ||
| ZEALAND PHARMA | 3 | 1 | +0,53 % | ||
| ORSTED | 1 | 17 | -1,92 % | ||
| DANSKE BANK | 1 | 10 | +1,32 % | ||
| JYSKE BANK | 1 | 3 | +0,60 % | ||
| TRYG | 1 | - | -1,09 % | ||
| ROYAL UNIBREW | 1 | - | -0,53 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Novo Nordisk: Denecimig (Mim8) significantly reduced annualized bleeding rate in people with hemophilia A, regardless of inhibitor status, in phase 3 data published in NEJM | 1.172 | PR Newswire | Published pivotal FRONTIER2 study showed investigational denecimig significantly reduced annualized bleeding rate compared to prior clotting factor prophylaxis and on-demand treatment in... ► Artikel lesen | |
| Mi | Zealand Pharma and Roche to advance weight loss drug to phase 3 | 7 | Investing.com | ||
| Mi | Zealand Pharma und Roche bringen Adipositas-Medikament in Phase-3-Studie | 5 | Investing.com Deutsch | ||
| Mi | Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management | 6 | GlobeNewswire (USA) | ||
| Mi | Carlsberg Sees Sales Growth Through 2026 Even As Iran Crisis Looms | 5 | ESM Magazine | ||
| Mi | Royal UNIBREW A/S: Annual General Meeting 2026 | 165 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT NO 22/2026 - April 29, 2026 On Wednesday, April 29, 2026, at 4 pm CEST Royal Unibrew A/S held its Annual General Meeting at which the below resolutions were made. Resolutions:... ► Artikel lesen | |
| Mi | KURSZIEL ANGEHOBEN bei Vestas Wind Systems: Hier baut sich gerade etwas Großes auf - Was ich meinen Lesern jetzt rate | Hebelschein-Spekulant | |||
| Mi | Canada approves generic version of Novo's Ozempic | 11 | Seeking Alpha | ||
| Mi | Eilmeldung am Abend: NOVO NORDISK A/S stürzt ab! | 40 | Maximilian Berger | ||
| Mi | JPMORGAN stuft NOVO NORDISK auf 'Neutral' | 673 | dpa-AFX-Analyser | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Novo Nordisk vor Zahlen auf "Neutral" mit einem Kursziel von 250 dänischen Kronen belassen. Richard Vosser verglich in einer... ► Artikel lesen | |
| Mi | Canada approves its first generic version of Novo's Ozempic | 10 | Financial Post | ||
| Mi | Vorteil auch für Versender: Lieferung: Keine Kühlkette für Wegovy | 22 | APOTHEKE ADHOC | ||
| Mi | DSV Q1 2026 slides: Schenker integration drives 75% revenue surge | 4 | Investing.com | ||
| Mi | DSV Q1 2026: Schenker-Integration sorgt für Umsatzsprung von 75 % | 2 | Investing.com Deutsch | ||
| Mi | DSV's air volumes see continued boost from Schenker takeover in first quarter | 4 | Air Cargo News | ||
| Mi | Schenker-Integration treibt DSV-Wachstum in Q1 2026 an | 3 | Investing.com Deutsch | ||
| Mi | Brauerei Carlsberg wächst trotz Krisensorgen | 5 | n-tv.de | ||
| Mi | Carlsberg reports solid soft drinks, alcohol-free growth in Q1 | 3 | Sharecast | ||
| Mi | Erstes Ozempic-Generikum genehmigt | 71 | n-tv.de | ||
| Mi | Danske Bank A/S: Reduction of share capital by cancellation of own shares | 4 | GlobeNewswire (USA) |